947 related articles for article (PubMed ID: 19474702)
1. Kallikrein-kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr309Lys.
Bork K; Kleist R; Hardt J; Witzke G
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):325-32. PubMed ID: 19474702
[TBL] [Abstract][Full Text] [Related]
2. C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: Implication for a role in hereditary angioedema.
Madsen DE; Sidelmann JJ; Biltoft D; Gram J; Hansen S
Biochim Biophys Acta; 2015 Jun; 1850(6):1336-42. PubMed ID: 25800206
[TBL] [Abstract][Full Text] [Related]
3. Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis.
Joseph K; Tholanikunnel TE; Kaplan AP
Ann Allergy Asthma Immunol; 2010 Jan; 104(1):50-4. PubMed ID: 20143645
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
Kaplan AP; Joseph K
Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
[TBL] [Abstract][Full Text] [Related]
5. Complement, coagulation and fibrinolytic parameters in hereditary angioedema (HAE).
Cullmann W; Kövary PM; Müller N; Dick W
Clin Exp Immunol; 1982 Sep; 49(3):618-22. PubMed ID: 7172497
[TBL] [Abstract][Full Text] [Related]
6. Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema.
Schapira M; Silver LD; Scott CF; Schmaier AH; Prograis LJ; Curd JG; Colman RW
N Engl J Med; 1983 May; 308(18):1050-3. PubMed ID: 6601240
[TBL] [Abstract][Full Text] [Related]
7. Ongoing contact activation in patients with hereditary angioedema.
Konings J; Cugno M; Suffritti C; Ten Cate H; Cicardi M; Govers-Riemslag JW
PLoS One; 2013; 8(8):e74043. PubMed ID: 24013493
[TBL] [Abstract][Full Text] [Related]
8. Studies on components of the plasma kallikrein-kinin system in plasma samples from normal individuals and patients with septic shock.
Aasen AO; Erichsen NS; Gallimore MJ; Amundsen E
Adv Shock Res; 1980; 4():1-10. PubMed ID: 6172027
[TBL] [Abstract][Full Text] [Related]
9. Studies of the mechanisms of bradykinin generation in hereditary angioedema plasma.
Joseph K; Tuscano TB; Kaplan AP
Ann Allergy Asthma Immunol; 2008 Sep; 101(3):279-86. PubMed ID: 18814451
[TBL] [Abstract][Full Text] [Related]
10. Activation of the plasma clotting, fibrinolytic, and kinin-kallikrein system in preterm infants with severe idiopathic respiratory distress syndrome.
Brus F; van Oeveren W; Okken A; Oetomo SB
Pediatr Res; 1994 Nov; 36(5):647-53. PubMed ID: 7877886
[TBL] [Abstract][Full Text] [Related]
11. Missense mutation Thr309Lys in the coagulation factor XII gene in a Spanish family with hereditary angioedema type III.
Prieto A; Tornero P; Rubio M; Fernández-Cruz E; Rodriguez-Sainz C
Allergy; 2009 Feb; 64(2):284-6. PubMed ID: 19178407
[TBL] [Abstract][Full Text] [Related]
12. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
Mitropoulos KA
Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760
[TBL] [Abstract][Full Text] [Related]
13. Chromogenic peptide substrate assays in patients with multiple trauma.
Kierulf P; Aasen AO; Aune S; Godal HC; Ruud TE; Vaage J
Acta Chir Scand Suppl; 1982; 509():69-72. PubMed ID: 6962622
[TBL] [Abstract][Full Text] [Related]
14. The bradykinin-forming cascade and its role in hereditary angioedema.
Kaplan AP; Joseph K
Ann Allergy Asthma Immunol; 2010 Mar; 104(3):193-204. PubMed ID: 20377108
[TBL] [Abstract][Full Text] [Related]
15. The intrinsic coagulation-kinin pathway, complement cascades, plasma renin-angiotensin system, and their interrelationships.
Kaplan AP; Ghebrehiwet B; Silverberg M; Sealey JE
Crit Rev Immunol; 1981 Sep; 3(1):75-93. PubMed ID: 7047077
[TBL] [Abstract][Full Text] [Related]
16. Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy.
Bork K; Wulff K; Hardt J; Witzke G; Staubach P
J Allergy Clin Immunol; 2009 Jul; 124(1):129-34. PubMed ID: 19477491
[TBL] [Abstract][Full Text] [Related]
17. Coagulation Factor XII Gene Mutation in Brazilian Families with Hereditary Angioedema with Normal C1 Inhibitor.
Moreno AS; Valle SO; Levy S; França AT; Serpa FS; Arcuri HA; Palma MS; Campos WN; Dias MM; Ponard D; Monnier N; Lunardi J; Bork K; Silva WA; Arruda LK
Int Arch Allergy Immunol; 2015; 166(2):114-20. PubMed ID: 25790805
[TBL] [Abstract][Full Text] [Related]
18. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
[TBL] [Abstract][Full Text] [Related]
19. Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels.
Joseph K; Tholanikunnel BG; Wolf B; Bork K; Kaplan AP
J Allergy Clin Immunol; 2016 Jun; 137(6):1822-1829.e1. PubMed ID: 26395818
[TBL] [Abstract][Full Text] [Related]
20. Chromogenic peptide substrates. Their use for the assay of factors in the fibrinolytic and the plasma kallikrein-kinin systems.
Friberger P
Scand J Clin Lab Invest Suppl; 1982; 162():1-298. PubMed ID: 6221396
[No Abstract] [Full Text] [Related]
[Next] [New Search]
